PRMPerimeter Solutions, Inc.
Chemicals & Allied Products
- Revenue
- $653M
- 16% YoY
- Operating margin
- -30.8%
- 4483% YoY
- EBITDA
- −$127M
- 305% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- —
- $1.1B net debt
- AI in 10-K
- —
Red flags 1 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear—Cash flow under 80% of net income
- Dilutive SBCClear3% of revenueOver 10% of revenue
- Payouts exceed cash flowClear17% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyFired42% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | — | $361M | $322M | $561M | $653M | 16% |
| Operating income | — | $130M | $94M | −$4M | −$201M | 5234% |
| Net income | −$662M | $92M | $68M | −$6M | −$206M | 3398% |
| Operating cash flow | — | −$40M | $193K | $188M | $238M | 26% |
| Capex | — | $9M | $9M | $16M | $30M | 91% |
| Stock-based comp | — | $15M | $2M | $13M | $17M | 30% |
| Buybacks | — | $49M | $64M | $14M | $40M | 180% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $8M · 4
- Net
- −$8M
Pay vs performance
| Year | CEO total comp | Comp actually paid | TSR (indexed) | Peer TSR |
|---|---|---|---|---|
| FY2025 | — | — | 229 | 127 |
| FY2024 | — | — | 107 | 111 |
| FY2023 | — | — | 38 | 110 |
| FY2022 | — | — | 76 | 91 |
| FY2021 | — | — | 116 | 97 |